ArticleHeliyon2024

TP53 and EGFR amplification are negative predictors of overall survival in patients diagnosed with non-small cell lung cancer with brain metastases.

Tao Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.